2021
DOI: 10.1161/jaha.121.021370
|View full text |Cite
|
Sign up to set email alerts
|

Endomyocardial Biopsy: The Forgotten Piece in the Arrhythmogenic Cardiomyopathy Puzzle

Abstract: Background Endomyocardial biopsy (EMB) is part of 2010 Task Force Criteria (TFC) for arrhythmogenic right ventricular cardiomyopathy (ARVC). However, its usage has been curtailed because of its low presumed diagnostic yield, and it is now a poorly used tool. This study aims to analyze the contribution of EMB to the final diagnosis of ARVC. Methods and Results We included 104 consecutive patients evaluated for a suspicion of ARVC, who were… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
9
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 18 publications
(10 citation statements)
references
References 35 publications
1
9
0
Order By: Relevance
“…In a very recent study, electroanatomic voltage mapping-guided EMB improved the 2010 ITF criteria diagnostic yield by upgrading one-third of the patients at risk to definite ACM with negligible complications. This study supports the notion that electroanatomic voltage mapping-guided EMB may still be a safe and useful tool for the diagnosis of ACM ( 71 ).…”
Section: Histopathological Features and Protein Markerssupporting
confidence: 86%
“…In a very recent study, electroanatomic voltage mapping-guided EMB improved the 2010 ITF criteria diagnostic yield by upgrading one-third of the patients at risk to definite ACM with negligible complications. This study supports the notion that electroanatomic voltage mapping-guided EMB may still be a safe and useful tool for the diagnosis of ACM ( 71 ).…”
Section: Histopathological Features and Protein Markerssupporting
confidence: 86%
“…However, considering that the sensitivity of EMB was low and the myocardium free wall of RV was thin, its application in ACM patients with HF is still controversial. From the recent study, the EMB is safe and helpful for further enhancing the diagnostic efficiency to the arrhythmogenic left ventricular cardiomyopathy, which posed a higher risk to HF stage progression [60]. More evidence will be needed to confirm the clinical value of EMB in the suspension ACM patients.…”
Section: Histopathological Characteristics and Endomyocardial Biopsymentioning
confidence: 98%
“… 6 , 7 Moreover, VM has been proved useful to increase the diagnostic yield of endomyocardial biopsies in RV cardiomyopathies. 8 …”
Section: Introductionmentioning
confidence: 99%